AB0966 PROPOSAL OF OUTCOME MEASURES TO BE USED ON A 12-MONTH OPEN LABEL DRUG TRIAL IN JUVENILE SYSTEMIC SCLEROSIS. RESULTS OF THE 3RD CONSENSUS MEETING IN HAMBURG DECEMBER 2018
Ivan Foeldvari(Center for Rheumatology), Daniel Furst, Michael Blakley(Indiana University Health), Kathryn S. Torok(University of Pittsburgh Medical Center), Clarissa Pilkington(Great Ormond Street Hospital), Vanessa Smith(Ghent University Hospital), Jordi Antón, Kim Fligelstone(Scleroderma and Raynaud's UK), Maurizio Cutolo(Ospedale Policlinico San Martino), Allison Zheng(University of California, Los Angeles), B. Crossfield Stevens, Patrícia Costa‐Reis(University of Lisbon), Dana Němcová(Charles University), Anne M. Stevens(Seattle Children's Hospital), Bernd Hinrichs(Asklepios Fachklinikum Brandenburg), Lusine Ambartsumyan(Seattle Children's Hospital), Francesco Del Galdo(University of Leeds), Christian Beyer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dinesh Khanna(University of Michigan), Özgür Kasapçopur(Istituto Giannina Gaslini), Megan L. Curran, LI Suzanne, Tamás Constantin, Christopher P. Denton(The Royal Free Hospital), Antonia Höger, Catherine H. Orteu(Royal Free London NHS Foundation Trust), Francesca Ingegnoli(University of Milan)
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699